As a consequence, LRRK2 regulates CI-M6PR trafficking, along with its cargo cathepsin D. These results strengthen the concept that the etiopathogenesis of PD is circumscribed by disrupted trafficking dynamics and identify potential therapeutic approaches in LRRK2 PD. This evidence concerns the gene IGF2R and Parkinson disease.